HomeCompareBWV vs ORCC

BWV vs ORCC: Dividend Comparison 2026

BWV yields 1109.88% · ORCC yields 9.79%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 BWV wins by $47035737.28M in total portfolio value
10 years
BWV
BWV
● Live price
1109.88%
Share price
$0.18
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$47035737.30M
Annual income
$39,954,235,177,691.26
Full BWV calculator →
ORCC
ORCC
● Live price
9.79%
Share price
$13.48
Annual div
$1.32
5Y div CAGR
-50%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$21.4K
Annual income
$1.04
Full ORCC calculator →

Portfolio growth — BWV vs ORCC

📍 BWV pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodBWVORCC
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, BWV + ORCC cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
BWV pays
ORCC pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

BWV
Annual income on $10K today (after 15% tax)
$94,339.62/yr
After 10yr DRIP, annual income (after tax)
$33,961,099,901,037.57/yr
ORCC
Annual income on $10K today (after 15% tax)
$832.34/yr
After 10yr DRIP, annual income (after tax)
$0.88/yr
At 15% tax rate, BWV beats the other by $33,961,099,901,036.68/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of BWV + ORCC for your $10,000?

BWV: 50%ORCC: 50%
100% ORCC50/50100% BWV
Portfolio after 10yr
$23517868.66M
Annual income
$19,977,117,588,846.15/yr
Blended yield
84.94%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on ORCC right now

BWV
Analyst Ratings
1
Buy
1
Hold
Consensus: Buy
Price Target
$4.00
+2119.8% upside vs current
Range: $4.00 — $4.00
Altman Z
-9.6
Piotroski
4/9
ORCC
Analyst Ratings
9
Buy
4
Hold
1
Sell
Consensus: Buy
Price Target
$16.00
+18.7% upside vs current
Range: $16.00 — $16.00
Altman Z
0.5
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

BWV buys
0
ORCC buys
0
No recent congressional trades found for BWV or ORCC in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricBWVORCC
Forward yield1109.88%9.79%
Annual dividend / share$2.00$1.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%-50%
Portfolio after 10y$47035737.30M$21.4K
Annual income after 10y$39,954,235,177,691.26$1.04
Total dividends collected$46502201.88M$1.0K
Payment frequencyquarterlyquarterly
SectorStockBDC
Analyst consensusBuyBuy
Analyst price target$4.00$16.00

Year-by-year: BWV vs ORCC ($10,000, DRIP)

YearBWV PortfolioBWV Income/yrORCC PortfolioORCC Income/yrGap
1← crossover$121,688$110,987.79$11,190$489.61+$110.5KBWV
2$1,392,436$1,262,229.83$12,229$256.01+$1.38MBWV
3$14,988,323$13,498,416.50$13,216$130.74+$14.98MBWV
4$151,830,358$135,792,852.99$14,207$66.02+$151.82MBWV
5$1,448,037,323$1,285,578,839.42$15,234$33.17+$1448.02MBWV
6$13,008,119,121$11,458,719,185.11$16,317$16.62+$13008.10MBWV
7$110,121,340,317$96,202,652,857.66$17,468$8.32+$110121.32MBWV
8$878,962,312,032$761,132,477,893.38$18,695$4.16+$878962.29MBWV
9$6,618,226,279,560$5,677,736,605,685.80$20,006$2.08+$6618226.26MBWV
10$47,035,737,296,821$39,954,235,177,691.26$21,407$1.04+$47035737.28MBWV

BWV vs ORCC: Complete Analysis 2026

BWVStock

Blue Water Vaccines, Inc., a biotechnology company, engages in the research and development of vaccines to prevent infectious diseases worldwide. The company's lead vaccine programs that are under preclinical development include BWV-101, an influenza vaccine; and BWV-102, a H1 pre-pandemic vaccine. It also has other pipeline under preclinical development comprising BWV-201, a streptococcus pneumoniae induced acute otitis media vaccine program; BWV-301, a norovirus-rotavirus vaccine program; and BWV-302, a norovirus-malaria vaccine program. The company was incorporated in 2018 and is based in Cincinnati, Ohio.

Full BWV Calculator →

ORCCBDC

Owl Rock Capital Corporation is a business development company. The fund makes investments in senior secured or unsecured loans, subordinated loans or mezzanine loans and also considers equity-related securities including warrants and preferred stocks also pursues preferred equity investments and common equity investments. Within private equity, it seeks to invest in growth, acquisitions, market or product expansion, refinancings and recapitalizations. It seeks to invest in middle market companies based in the United States, with EBITDA between $10 million and $250 million annually and/or annual revenue of $50 million and $2.5 billion at the time of investment.

Full ORCC Calculator →
📬

Get this BWV vs ORCC comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

BWV vs SCHDBWV vs JEPIBWV vs OBWV vs KOBWV vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.